Unilever agreed to sell its global tea business, ekaterra, to CVC Capital Partners Fund VIII. The deal is structured as a full‑control carve‑out, with Unilever retaining its tea operations in India, Nepal, Indonesia, and its 50% stake in the Pepsi‑Lipton ready‑to‑drink tea joint venture and related distribution businesses, while the ekaterra perimeter includes all other tea brands and production assets. The transaction was the result of a competitive, multi‑bidder process advised by Goldman Sachs and Centerview Partners on the sell‑side, with CVC’s offer—prepared with Spayne Lindsay & Co and Citigroup—outperforming competing bids from Carlyle and Advent. By exiting ekaterra, Unilever executes a strategic portfolio reshaping focused on reallocating capital toward higher‑growth, more digitally oriented and premium consumer‑segments, while CVC takes over a platform‑scale tea business, strong brand equity, and a diversified footprint across nearly 80 countries.

LIPTON TEAS AND INFUSIONS, which reported an EBITDA margin of LOGIN in 2021, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the average currently observed in the AgriFood sector (10.3x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.